Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Brain Metastases
Interventions: DRUG: Eribulin Mesylate|DEVICE: MRI|DRUG: Pre-Medication: Zofran|DRUG: Pre-Medication: Decadron
Sponsor: Case Comprehensive Cancer Center